Elisa Longhitano

ORCID: 0000-0002-5222-4431
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Renal Diseases and Glomerulopathies
  • Chronic Kidney Disease and Diabetes
  • Pregnancy and Medication Impact
  • Pregnancy and preeclampsia studies
  • Diet and metabolism studies
  • Parathyroid Disorders and Treatments
  • Birth, Development, and Health
  • Climate Change and Health Impacts
  • Systemic Lupus Erythematosus Research
  • Nutritional Studies and Diet
  • Diabetes Treatment and Management
  • Electrolyte and hormonal disorders
  • Nutrition and Health in Aging
  • Biomedical Research and Pathophysiology
  • Health Systems, Economic Evaluations, Quality of Life
  • Neurological and metabolic disorders
  • Myasthenia Gravis and Thymoma
  • Maternal and fetal healthcare
  • Magnesium in Health and Disease
  • Vasculitis and related conditions
  • Muscle and Compartmental Disorders
  • Liver Disease Diagnosis and Treatment
  • Reproductive System and Pregnancy
  • Renal and Vascular Pathologies

University of Messina
2020-2025

Centre Hospitalier du Mans
2020-2024

Azienda Ospedaliera Universitaria Policlinico "G. Martino"
2020-2024

Azienda Ospedaliero-Universitaria di Modena
2008

Incremental hemodialysis (iHD) may attenuate "dialysis shock" and reduce costs, preserving quality of life. It is considered difficult to reconcile with HD wards' routine; fear underdialysis increasing mortality are additional concerns. The aim this study was evaluate mortality, morbidity, costs in a large ward where iHD the standard start. This observational included all incident patients 2017 2021, stratified according start: (1-2 sessions/wk), decremental (dHD, 3 sessions/wk at start,...

10.1016/j.ekir.2022.02.010 article EN cc-by-nc-nd Kidney International Reports 2022-02-19

Little is known about the effect tubulointerstitial nephropathies have in modulating maternal-fetal outcomes pregnancy. Therefore, we analyzed main of pregnancy these women to gain a better understanding role reduction maternal kidney mass. From Torino Cagliari Observational Study (TOCOS) cohort, selected 529 patients with diagnosis disease and focused on 421 chronic (CKD) stage 1, without hypertension but proteinuria less than 0.5 g/day at referral. cohort 2969 singleton deliveries from...

10.1016/j.kint.2023.12.018 article EN cc-by-nc-nd Kidney International 2024-01-29

Hypercalcemia is defined as a serum calcium concentration higher than 10.5 mg/gL or 2.6 mmol/L. Only 50% of active, presented ionized calcium. The remaining half bound to albumin, phosphate, and other anions, their changes can affect the concentration. Thus, discriminate true hypercalcemia from pseudo hypercalcemia, an 1.3 mmol/L might be more appropriate. Many variables lead managing them necessary treat this ion disorder. Indeed, it caused by malignancies, hematologic disorders, genetic...

10.3390/kidneydial5010007 article EN cc-by Kidney and Dialysis 2025-02-06

Introduction. Treating hyperkalemia is one of the main goals supportive care in patients on hemodialysis. In this context, therapy with new potassium binders a promising resource. Objective. The aim to evaluate difference serum concentration after treatment sodium zirconium cyclosilicate or patiromer compared placebo/sodium polystyrene sulfonate/calcium sulfonate. Methods. We will perform systematic research PubMed, EMBASE, CINAHLE, and grey literature be screened. screen RCTs treated SZC...

10.69097/42-01-2025-02 article EN PubMed 2025-02-28

Abstract: Hyperphosphataemia represents a significant challenge in the management of chronic kidney disease, exerting pronounced influence on pathogenesis cardiovascular complications and mineral bone disorders. Traditional approaches to address hyperphosphataemia involve implementing dietary phosphate restrictions, administering binders, and, cases end-stage renal resorting dialysis. Unfortunately, these interventions frequently prove inadequate maintaining levels within recommended ranges....

10.2147/ijnrd.s385826 article EN cc-by-nc International Journal of Nephrology and Renovascular Disease 2024-05-01

Chronic kidney disease (CKD) is widespread throughout the world, with a high social and health impact. It considered 'silent killer' for its sudden onset without symptoms in early stages of disease. The main goal nephrologists to slow progression treat associated range new medications.

10.1080/13543784.2024.2326624 article EN Expert Opinion on Investigational Drugs 2024-03-02

Prescribing a low-protein diet (LPD) is part of the standard management patients in advanced stages chronic kidney disease (CKD). However, studies on quality life (QoL) LPDs are lacking, and impact these diets have their QoL often given as reason for not prescribing one. We, therefore, decided to assess cohort CKD stage 3–5 followed up by multiple-choice approach an outpatient nephrology clinic France. To do so, we used short version World Health Organization’s questionnaire compared results...

10.3390/nu13041354 article EN Nutrients 2021-04-18

(1) Background: This observational study aimed to verify the association between serum potassium levels and hospitalization days in patients with chronic kidney disease a follow up of nine months. (2) Methods: Patients were divided into group A (180 patients, ≤ 5.1 mEq/L) B (90 > mEq/L). Student's t-test, Mann-Whitney test, Pearson's Chi-Square Pearson/Spearman's correlation test linear regression performed entire sample stage-G4/5 subsample. (3) Results: Groups differed for estimated...

10.3390/jcm11010244 article EN Journal of Clinical Medicine 2022-01-04

Background: Pregnancy involves complex hemodynamic and immune adaptations to support the developing fetus. The kidney assumes a pivotal role in orchestrating these mechanisms. However, renal disease poses potential risk for adverse maternal–fetal outcomes. While function, hypertension, proteinuria are recognized as key influencers of risk, mere presence glomerular disease, independent factors, may wield significant impact. Methods: A brief review existing literature was conducted synthesize...

10.3390/jcm13061693 article EN Journal of Clinical Medicine 2024-03-15

ABSTRACT Pregnancy in women living with chronic kidney disease (CKD) was often discouraged due to the risk of adverse maternal–fetal outcomes and progression disease. This negative attitude has changed recent years, greater emphasis on patient empowerment than imperative ‘non nocere’. Although risks persist, pregnancy even advanced CKD have significantly improved, for both mother newborn. Adequate counselling can help minimize support a more conscious informed approach those that are...

10.1093/ckj/sfae084 article EN cc-by Clinical Kidney Journal 2024-03-21

Audits allow analysis of the delivery care and prevalence diseases. This study investigated kidney diseases’ impact on end-stage renal disease (ERSD) in patients younger than 30 years. Methods: is retrospectively conducted young dialysis-dependent included Sicilian Registry Nephrology, Dialysis Transplantation Participants. It evaluated who started dialysis before age retrieved mentioned registry. The sample was divided into two groups, according to presence or absence a specific diagnosis....

10.3390/medicina60122031 article EN cc-by Medicina 2024-12-09
Coming Soon ...